Skip to main content

INVESTING IN INNOVATION

Commercialising world class research from UCL

£0M

HAS been invested in UCL projects

0

Proof of concept investments

0

PORTFOLIO COMPANIES

0

Licensing projects

Achilles Therapeutics Announces Pricing of Initial Public Offering

UCL Technology Fund secures partnership with Viralgen, leading gene therapy manufacturer

UCL, Imperial College London and University of Cambridge are behind innovative industry university collaboration receiving £100m funding to rapidly advance cutting-edge science

NovalGen doses first patient in Phase I study in Chronic Lymphocytic Leukemia & Mantle Cell Lymphoma

Intrinsic closes £1.35m seed funding round to prototype next generation memory devices

UCLTF Showcase 2021 - The Highlights